StonvexLoading…
StonvexCore line items from NXST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.40B | $4.95B | $3.66B | $2.46B |
Operating Income | $265.00M | $849.00M | $607.00M | $432.00M |
Net Income | $164.00M | $109.00M | $275.00M | $205.00M |
EPS (Diluted) | $5.09 | $3.00 | $8.57 | $6.43 |
Total Assets | $18.10B | $10.85B | $11.25B | $11.33B |
Total Liabilities | $15.94B | $8.78B | $8.96B | $9.07B |
Cash & Equivalents | $379.00M | $280.00M | $236.00M | $234.00M |
Free Cash Flow OCF − CapEx | $267.00M | $743.00M | $607.00M | $520.00M |
Shares Outstanding | 30.54M | 30.33M | 30.70M | 30.72M |